Both are possible, but I suspect the answer is somewhere in the middle. That’s still a multi bagger because the market is pricing in almost total failure.
Besides other initiatives, one thing that’s been completely forgotten by the market is the huge volume potential of Astra Zeneca smart inhalers as they roll out in North America.
Both are possible, but I suspect the answer is somewhere in the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $13.65M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.7¢ | $7.436K | 434.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 194311 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 185999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| ADR (ASX) Chart |